(1)  In this regulation –

school first aid kit means a first aid kit used for the purposes of a school or TasTAFE.

(2)  A pharmaceutical chemist must not supply a potent substance unless –

(a) the supply is made on the authority of a medical practitioner, veterinary surgeon, dentist, endorsed midwife, authorised health professional or authorised nurse practitioner, whether given in the form of a prescription or otherwise; or

(b) the pharmaceutical chemist, or a pharmaceutical chemist or pharmacy trainee employed by that pharmaceutical chemist –

(i) participates personally and directly in the supply of the substance; and

(ii) on consideration of the condition, disease or symptoms of the person for whom, or the animal for which, the substance is supplied (in this regulation referred to as "the patient" ) forms the opinion that the use of that substance in the treatment of the patient is justified; or

(c) the supply is made for a school first aid kit in accordance with the written authority of the school principal or the TasTAFE chief executive officer; or

(d) the supply is made to a person or class of persons approved by the Secretary as having sufficient expertise to administer the substance.

Penalty:  Fine not exceeding 10 penalty units.

(3)  A pharmaceutical chemist must not supply a Schedule 2 substance that is a specified potent substance, other than salbutamol (S3) supplied for a school first aid kit in accordance with the written authority of the school principal or the TasTAFE chief executive officer, unless its container is labelled in accordance with regulation 114(2) .

Penalty:  Fine not exceeding 10 penalty units.

(4)  A pharmaceutical chemist must not supply salbutamol (S3) for a school first aid kit otherwise than in accordance with subregulation (5)(b) .

Penalty:  Fine not exceeding 10 penalty units.

(5)  A pharmaceutical chemist must not supply a Schedule 2 substance that is not a specified potent substance unless –

(a) its container is labelled in accordance with regulation 114(2) ; or

(b) in addition to its container and any primary pack conforming to the requirements applicable under Part 6  –

(i) its container bears a label that identifies the pharmacy from which it was supplied; and

(ii) there are supplied with it directions for its use as specified in subregulation (6) .

Penalty:  Fine not exceeding 10 penalty units.

(6)  The directions referred to in Subregulation (5)(b)(ii) for the use of a substance are to comprise either –

(a) adequate written directions, on a label on its container, for its use specifically in the treatment of the patient; or

(b) both of the following:

(i) written directions, on a label on its container, for its use generally;

(ii) an oral explanation of the specific application of those directions in relation to the treatment of the patient, being an explanation given by a pharmaceutical chemist or a pharmacy trainee to the patient or, where the potent substance is to be administered to the patient by another person, to that other person.

(7)  Notwithstanding this regulation, a pharmaceutical chemist may supply the following substances to a person who may be required to administer those substances for the purposes specified:

(a) adrenaline (S3) for the treatment of anaphylaxis;

(b) naloxone (S3) for the treatment of opioid toxicity.